Targeted delivery of nanoparticles for in vivo CAR T therapy

Strike Pharma is a Swedish biotech company with a proprietary technology for targeted LNP delivery, enabling in vivo CAR-T therapies for autoimmune disease and cancer. Specifically our technology provides a solution for CMC challenges related to long-term storage, based on an affinity conjugation technology that allows post-storage attachment the targeting antibody to the LNP.

Learn more about our Technology, Pipeline and Disease indications, and see our Publications and posters.